Abstract:
Since many years, medicines’ supply chain in Rwanda knew many inefficiencies—from poor
quantification, fragmented distribution, and inexistence of a harmonized logistics information
system in health. This has led to a disruption in the health commodity supply chain and the
government’s ability to achieve its health goals has been compromised. The remediation of these
problems, has been the establishment of new strategies by the Government of Rwanda (GOR)
and the partnership with stakeholders to make more strong and sustainable its supply chain
management. Regardless of the significant efforts that used and put in place to enhance supply
chain performance in Rwanda, reports done by the Auditor General, have revealed consistent
problems related to poor inventory management and big loss due to expiry of medicines at
MPPD. From there, it’s important that in-depth exploration be done to understand the status of
expiry in detail at Central medical store and identify the factors that contribute to expiry of
medicines at that level. The aim of this research was to assess the factors that contribute to or
cause expiry of medicines at MPPD and from there formulate some recommendations for the
improvement of the current situation. The questionnaire containing closed-ended items has been
used during this study. Multiple choices have been given and the respondents were asked to tick
appropriate choices. The study found that the total expired products were RWF 6,046,777,655
for all program categories: HIV commodities had the largest share 53.3%, Essential Medicines
22.5%, Malaria 13%, Maternal Child Health commodities 5.7%, Products used for Community
health workers 4.5%, TB products 1% and 0.1% for Family Planning products. The study
indicated that 60% of the respondents agree that excess drug supply affects the expiry of
medicines at MPPD,20% agreed that poor storage conditions affect the expiry of medicines at
MPPD against 56% who disagreed that poor conditions affect the expiry of medicines at MPPD,
32% of respondents agreed that supply chain management affects the expiry of medicines at
MPPD and for other factors all the statements were agreeable with a percentage above 60 (Rare
diseases affect the expiry of medicines at MPPD 88%, Abrupt cessation of use/treatment policy
change affects the expiry of medicines at MPPD 80%, Short shelf life affect the expiry of
medicines at MPPD 72%, Expensive medicine affects the expiry of medicines at MPPD 72% and
donation of management affects the expiry of medicines at MPPD 68% and). The study
recommended that further research should be done on the factors that contribute to or cause
expiry of medicines at MPPD concerning especially how the institution is accountable on the
iii
management of products subsidized where Government is funded by donors because they are
many that expire at MPPD. Further research should also be conducted on the contribution of
customer relationship management on the expiry of medicines at MPPD. There is a need for
other researchers to undertake similar studies to ascertain how different institutions (public or
private) deal with the issues of medicine expiry.